These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3263396)

  • 1. Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.
    Stromski ME; van Waarde A; Avison MJ; Thulin G; Gaudio KM; Kashgarian M; Shulman RG; Siegel NJ
    J Clin Invest; 1988 Nov; 82(5):1694-9. PubMed ID: 3263396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance.
    Dhasmana JP; Digerness SB; Geckle JM; Ng TC; Glickson JD; Blackstone EH
    J Cardiovasc Pharmacol; 1983; 5(6):1040-7. PubMed ID: 6196552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 5. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of the kidney against ischemic injury by inhibition of 5'-nucleotidase.
    Van Waarde A; Stromski ME; Thulin G; Gaudio KM; Kashgarian M; Shulman RG; Siegel NJ
    Am J Physiol; 1989 Feb; 256(2 Pt 2):F298-305. PubMed ID: 2537026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypnotic effects of deoxycorformycin in rats.
    Radulovacki M; Virus RM; Djuricic-Nedelson M; Green RD
    Brain Res; 1983 Jul; 271(2):392-5. PubMed ID: 6604561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine and hypoxic vasodilatation.
    Dóra E
    J Cereb Blood Flow Metab; 1985 Dec; 5(4):621-4. PubMed ID: 3877069
    [No Abstract]   [Full Text] [Related]  

  • 11. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
    Jackson RC; Leopold WR; Ross DA
    Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
    Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
    Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced recovery of renal ATP with postischemic infusion of ATP-MgCl2 determined by 31P-NMR.
    Siegel NJ; Avison MJ; Reilly HF; Alger JR; Shulman RG
    Am J Physiol; 1983 Oct; 245(4):F530-4. PubMed ID: 6605093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and functional correlates of postischemic renal ATP levels.
    Stromski ME; Cooper K; Thulin G; Gaudio KM; Siegel NJ; Shulman RG
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6142-5. PubMed ID: 3461481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
    Gilbertsen RB
    J Immunopharmacol; 1985; 7(3):325-41. PubMed ID: 3877119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
    Mitchell BS; Sidi Y; Hershfield M; Koller CA
    Ann N Y Acad Sci; 1985; 451():129-37. PubMed ID: 3878114
    [No Abstract]   [Full Text] [Related]  

  • 17. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
    Franco R; Hoyle CH; Centelles JJ; Burnstock G
    Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
    Holland MJ
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract]   [Full Text] [Related]  

  • 20. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
    Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.